Target intelligence / Profile preview

RNA, U4atac small nuclear 4, pseudogene (RNU4ATAC4P)

Target
RNU4ATAC4P
Molecular classification
Other (Pseudogene), Non-coding RNA pseudogene
01

Overview

**RNU4ATAC4P** is designated as a pseudogene related to the U4atac small nuclear RNA family. Pseudogenes are genomic sequences similar to known genes but are typically nonfunctional; they do not produce active protein or RNA products and, as such, do not directly participate in biological processes or serve as targets for drugs. The functional RNU4ATAC gene encodes the U4atac small nuclear RNA, an essential component of the minor spliceosome complex involved in the splicing of U12-type introns from pre-mRNAs[3][5]. However, RNU4ATAC4P itself is annotated as a pseudogene and is not known to produce a functional RNA product. It does not play a documented role in human disease, is not regarded as a therapeutic target, and has no known associated drugs, mechanism of action, biomarkers, or safety profile. The information for RNU4ATAC4P is distinct from that describing the functional RNU4ATAC gene. For the study or targeting of spliceosomal function or related diseases, the relevant entity would be the functional RNU4ATAC gene, not its pseudogene[5]. Key points: - **RNU4ATAC4P is a pseudogene and not a molecular target.** - It has no known molecular function, biological roles, or clinical relevance as a target. - Most literature and resources focus on the functional RNU4ATAC gene and its involvement in rare developmental disorders[3][5]. - The entry appears to be largely informational and not relevant for drug targeting, therapeutic intervention, or biomarker development.

Other names
RNU4ATAC4P

Beyond the preview

Go deeper on RNA, U4atac small nuclear 4, pseudogene (RNU4ATAC4P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4atac small nuclear 4, pseudogene (RNU4ATAC4P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call